Glass House Brands (GLAS) Current Taxes (2020 - 2025)
Glass House Brands' (GLAS) quarterly Current Taxes came in at $2.4 million in Q3 2025, down 45.17% year-on-year from $4.4 million in Q3 2024, and down 35.36% on a QoQ basis from $3.7 million in Q2 2025.
Glass House Brands (GLAS) Current Taxes (2020 - 2025) Analysis & Trends
Glass House Brands (GLAS) has 6 years of Current Taxes data on file, last reported at $2.4 million in Q3 2025.
- On a quarterly basis, Current Taxes fell 45.17% year-over-year to $2.4 million in Q3 2025; TTM through Sep 2025 was $2.4 million, a 45.17% decrease from a year earlier, with the FY2024 full-year figure at $2.4 million, down 69.44% from the prior year.
- Current Taxes for Q3 2025 stood at $2.4 million, down from $3.7 million in the prior quarter.
- Over the last five years, Current Taxes for GLAS reached as high as $20.6 million in Q3 2023 and fell as low as $2.4 million in Q4 2024.
- Historically, Current Taxes has averaged $7.4 million across 5 years, with a median of $7.3 million in 2022.
- Across the five-year window, Current Taxes soared 108.43% in 2023 and tumbled 78.72% in 2024, its largest moves.
- Year by year, Current Taxes stood at $3.8 million in 2021, then jumped by 99.55% to $7.6 million in 2022, then increased by 3.66% to $7.9 million in 2023, then tumbled by 69.44% to $2.4 million in 2024, then changed by 0.0% to $2.4 million in 2025.
- Per Business Quant data, the three most recent Current Taxes figures were $2.4 million in Q3 2025, $3.7 million in Q2 2025, and $2.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 4.39 Mn |
| Jun 30, 2024 | 7.71 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 7.88 Mn |
| Sep 30, 2023 | 20.64 Mn |
| Jun 30, 2023 | 14.74 Mn |
| Mar 31, 2023 | 9.61 Mn |
| Dec 31, 2022 | 7.60 Mn |
| Sep 30, 2022 | 11.06 Mn |
| Jun 30, 2022 | 7.07 Mn |
| Mar 31, 2022 | 5.48 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Jun 30, 2021 | 7.64 Mn |
| Mar 31, 2021 | 6.43 Mn |
| Dec 31, 2020 | 4.95 Mn |